Who owns Spero Therapeutics Inc?
- Ticker: SPRO
- CUSIP Number: 84833t103
Tip: Access positions for across all investors
Analyze quarterly positions in Spero Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Spero Therapeutics stock
Who bought or sold Spero Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Pfizer | 2.4M | $5.5M | 0% | Dec 2025 |
|
| Vanguard Group | 2.1M | $4.9M | 5% | Dec 2025 |
|
| Renaissance Technologies | 1.3M | $3.0M | -12% | Dec 2025 |
|
| Alphabet | 890k | $2.1M | 0% | Dec 2025 |
|
| Frigate Ventures | 625k | $1.5M | -61% | Dec 2025 |
|
| Geode Capital Management | 529k | $1.2M | 0% | Dec 2025 |
|
| BlackRock | 434k | $1.0M | 0% | Dec 2025 |
|
| Susquehanna International | 294k | $684k | 2594% | Dec 2025 |
|
| Eudaimonia Asset Management | 218k | $508k | -23% | Dec 2025 |
|
| State Street Corporation | 210k | $490k | 10% | Dec 2025 |
|
| Ionic Capital Management | 209k | $392k | 39% | Sep 2025 |
|
| Jane Street | 197k | $459k | 358% | Dec 2025 |
|
| GSA Capital Partners | 179k | $417k | 67% | Dec 2025 |
|
| Intrepid Family Office | 165k | $385k | 50% | Dec 2025 |
|
| Sei Investments | 132k | $0 | 100% | Dec 2025 |
|
| OMERS Administration Corporation | 131k | $306k | 100% | Dec 2025 |
|
| Northern Trust | 121k | $282k | -7% | Dec 2025 |
|
| Squarepoint Ops | 119k | $278k | 100% | Dec 2025 |
|
| UBS Group | 116k | $271k | 330% | Dec 2025 |
|
| Bridgeway Capital Management | 115k | $216k | 0% | Sep 2025 |
|
| ADAR1 Capital Management | 114k | $265k | -1% | Dec 2025 |
|
| None | 60k | $141k | 100% | Dec 2025 |
|
| Citadel Advisors | 55k | $103k | -77% | Sep 2025 |
|
| Two Sigma Investments | 49k | $93k | 100% | Sep 2025 |
|
| Point72 Asset Management | 44k | $102k | 100% | Dec 2025 |
|
| Cubist Systematic Strategies | 41k | $77k | 50% | Sep 2025 |
|
| Quadrature Capital | 38k | $88k | 100% | Dec 2025 |
|
| Simplex Trading | 36k | $83k | 368% | Dec 2025 |
|
| Capital Asset Advisory Services | 33k | $82k | 0% | Dec 2025 |
|
| Axxcess Wealth Management | 33k | $76k | 0% | Dec 2025 |
|
| Three Seasons Wealth | 30k | $70k | 0% | Dec 2025 |
|
| Dimensional Fund Advisors | 30k | $69k | 3% | Dec 2025 |
|
| Charles Schwab Investment Management | 29k | $67k | 0% | Dec 2025 |
|
| Invesco | 25k | $58k | 12% | Dec 2025 |
|
| Assenagon Asset Management | 19k | $43k | -50% | Dec 2025 |
|
| XTX Topco | 15k | $35k | -55% | Dec 2025 |
|
| Yale Capital Corp. | 10k | $23k | 0% | Dec 2025 |
|
| Tower Research Capital | 7.2k | $17k | 100% | Dec 2025 |
|
| Jones Financial Companies, L.L | 6.5k | $15k | 100% | Dec 2025 |
|
| FNY Investment Advisers | 5.3k | $12k | 0% | Dec 2025 |
|
| Cullen Frost Bankers | 3.0k | $7.0k | 100% | Dec 2025 |
|
| FMR | 550.00 | $1.0k | 100% | Sep 2025 |
|
| Advisor Group Holdings | 290.00 | $675.004000 | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 236.00 | $444.010400 | 100% | Sep 2025 |
|
| Wells Fargo & Company | 200.00 | $466.000000 | 0% | Dec 2025 |
|
| Rockefeller Capital Management | 200.00 | $466.000000 | 0% | Dec 2025 |
|
| Us Bancorp | 151.00 | $351.996100 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 40.00 | $93.000000 | 0% | Dec 2025 |
|
| SageView Advisory Group | 17.00 | $39.999300 | 100% | Dec 2025 |
|
| Farther Finance Advisors | 10.00 | $23.000000 | 100% | Dec 2025 |
|
| SBI Securities | 9.00 | $20.999700 | -10% | Dec 2025 |
|
Who sold out of Spero Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Arrowstreet Capital, Limited Partnership | Sep 2025 | 151k | $283k |
| Shay Capital | Sep 2025 | 64k | $120k |
| American Century Companies | Sep 2025 | 40k | $76k |
| Rangeley Capital | Sep 2025 | 30k | $56k |
| Group One Trading | Sep 2025 | 17k | $32k |
| Royal Bank of Canada | Jun 2025 | 5.7k | $17k |
| Goss Wealth Management | Sep 2025 | 100.00 | $188.000000 |